Table 2.
Population Characteristics
| Prevention Cohort | |||
|---|---|---|---|
| Primary(N= 2,544) | Secondary (N= 2,258) | P Value | |
| Demographics | |||
| Mean age, y (±SD) | 56.7 (12.9) | 63.2 (12.1) | <.0001 |
| Male, % | 52.9 | 59.5 | <.0001 |
| Race, % | |||
| White | 81.0 | 82.7 | <.0001 |
| African-American | 5.8 | 8.8 | |
| Other | 13.2 | 8.5 | |
| Married, % | 72.4 | 70.2 | NS |
| Statin naive, % | 54.0 | 54.4 | NS |
| Health Care Utilization | |||
| Cardiologist visits per year, mean (±SD) | 0.1 (0.7) | 1.5 (3.1) | <.0001 |
| Number of LDL tests per year, mean (±SD) | 2.4 (4.0) | 3.8 (5.5) | <.0001 |
| Prescription copayment, mean (±SD) | $9.92 (7.24) | $11.23 (8.07) | <.0001 |
| Medication Regimen | |||
| Single brand/strength regimens only, % | 64.3 | 53.2 | <.0001 |
| Once daily regimens only, % | 90.1 | 83.6 | <.0001 |
| Days supply count per Rx, mean (±SD) | 39.0 (18.4) | 39.3 (17.5) | NS |
SD, standard deviation; LDL, low-density lipoprotein; NS, not significant.